Fleming S J, Wilkinson J S, Aldridge C, Greenwood R N, Muggleston S D, Baker L R, Cattell W R
Department of Nephrology, St. Bartholomews Hospital, London, England.
Clin Nephrol. 1988 Feb;29(2):63-8.
Blood volume (BV) change during hemodialysis is often monitored by packed cell volume (PCV). This assumes erythrocyte volume is constant. We tested this by dialyzing 5 patients for 2 hours against high (154 mmol/l), normal (140 mmol/l) and low (126 mmol/l) dialysate sodium concentrations. Erythrocyte water content, calculated from measured blood and plasma water contents, decreased with high and increased with low dialysate sodium concentrations. Erythrocyte volume, calculated from mean corpuscular hemoglobin concentration (MCHC) decreased 3.8% with high concentration dialysate and increased 2.5% when dialysate concentration was low. These changes correlated significantly (r = 0.80, p less than 0.01) with alterations in plasma sodium. Mean corpuscular volume (MCV), measured with a Coulter-S Plus Counter did not alter because of a methodological artefact. BV change can be calculated from PCV when plasma concentrations of osmotically active substances are changed only if allowance is made for altered erythrocyte volume.
血液透析期间的血容量(BV)变化通常通过血细胞比容(PCV)来监测。这假定红细胞体积是恒定的。我们通过让5名患者分别使用高钠(154 mmol/l)、正常钠(140 mmol/l)和低钠(126 mmol/l)透析液进行2小时的透析来对此进行测试。根据测得的血液和血浆含水量计算得出的红细胞含水量,在使用高钠透析液时降低,而在使用低钠透析液时升高。根据平均红细胞血红蛋白浓度(MCHC)计算得出的红细胞体积,在使用高浓度透析液时降低了3.8%,而在透析液浓度较低时增加了2.5%。这些变化与血浆钠的改变显著相关(r = 0.80,p小于0.01)。使用库尔特S Plus血细胞计数器测量的平均红细胞体积(MCV)未因方法学假象而改变。只有在考虑到红细胞体积改变的情况下,当渗透活性物质的血浆浓度发生变化时,才能根据PCV计算BV变化。